Skip to main content
. 2010 Sep 1;101(11):2384–2390. doi: 10.1111/j.1349-7006.2010.01684.x

Figure 5.

Figure 5

 Expression of interleukin‐17 (IL‐17), vascular endothelial growth factor‐C (VEGF‐C) and D2‐40 in tumors from non‐small‐cell lung cancer (NSCLC) patients in situ. High expression of IL‐17 (A), VEGF‐C (B) and D2‐40 (C) on sections of case 18. Low expression of IL‐17 (D), VEGF‐C (E) and D2‐40 (F) on sections of case 10 (magnification, ×200).